The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Self-citationOnce-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Harris, S. T. (1999) · JAMA · doi:10.1001/jama.282.14.1344 · Cited by 2,475
Self-citationShane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003 · cited 3×
“Acute phase reactions with transient, mild to moderate influenza-like symptoms occur with monthly oral(68,69) or intravenous bisphosphonate therapy.(9,10,70,71)”
BackgroundEffect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Self-citationKhosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650
Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580
Russell, R. G. G., Watts, N. B., Ebetino, F. H., & Rogers, M. J. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0540-8 · Cited by 1,411
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Self-citationTen Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Chesnut, C. H., Skag, A., Christiansen, C., Recker, R., Stakkestad, J. A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040325 · Cited by 1,229
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
Alendronate for the Treatment of Osteoporosis in Men
Orwoll, E., Ettinger, M., Weiss, S., Miller, P., Kendler, D., Graham, J., Adami, S., Weber, K., Lorenc, R., Pietschmann, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430902 · Cited by 973
Self-citationEsophagitis Associated with the Use of Alendronate
de Groen, P. C., Lubbe, D. F., Hirsch, L. J., Daifotis, A., Stephenson, W., Freedholm, D., Pryor-Tillotson, S., Seleznick, M. J., Pinkas, H., & Wang, K. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351403 · Cited by 764
Marx, R. E., Cillo, J. E., & Ulloa, J. J. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.08.003 · Cited by 720
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700
Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
Schilcher, J., Michaëlsson, K., & Aspenberg, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010650 · Cited by 695
EFFECT OF RISEDRONATE ON THE RISK OF HIP FRACTURE IN ELDERLY WOMEN
Lung, R. M. C. C., Eusens, P. I. G., Aul, P., Iller, D. M., Ippel, H. A. Z., Ensen, W. I. G. B., Oux, C. H. R., Dami, S. I. A., Ogelman, I. G. F., Astell, R. I. E., et al. (2001) · Cited by 682
Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia
Mavrokokki, T., Cheng, A., Stein, B., & Goss, A. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.10.061 · Cited by 650
Khosla, S. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.01.054 · Cited by 564
MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-3-200802050-00198 · Cited by 529
Wallach, S., Cohen, S., Reid, D. M., Hughes, R. A., Hosking, D. J., Laan, R. F., Doherty, S. M., Maricic, M., Rosen, C., Brown, J., et al. (2000) · Calcified Tissue International · doi:10.1007/s002230001146 · Cited by 513
Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
Lo, J. C., O'Ryan, F. S., Gordon, N. P., Yang, J., Hui, R. L., Martin, D., Hutchinson, M., Lathon, P. V., Sanchez, G., Silver, P., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.03.050 · Cited by 493
Migliorati, C. A., Schubert, M. M., Peterson, D. E., & Seneda, L. M. (2005) · Cancer · doi:10.1002/cncr.21130 · Cited by 489
Incidence of atypical nontraumatic diaphyseal fractures of the femur
Dell, R. M., Adams, A. L., Greene, D. F., Funahashi, T. T., Silverman, S. L., Eisemon, E. O., Zhou, H., Burchette, R. J., & Ott, S. M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1719 · Cited by 441
Development and use of FRAX® in osteoporosis
Kanis, J. A., McCloskey, E. V., Johansson, H., Oden, A., Ström, O., & Borgström, F. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1253-y · Cited by 402
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00071.x · Cited by 384
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study
Lenart, B. A., Neviaser, A. S., Lyman, S., Chang, C. C., Edobor-Osula, F., Steele, B., van der Meulen, M. C. H., Lorich, D. G., & Lane, J. M. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0805-x · Cited by 384
Chesnut, C. H., McClung, M. R., Ensrud, K. E., Bell, N. H., Genant, H. K., Harris, S. T., Singer, F. R., Stock, J. L., Yood, R. A., Delmas, P. D., et al. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80134-x · Cited by 365
Self-citationHellstein, J. W., Adler, R. A., Edwards, B., Jacobsen, P. L., Kalmar, J. R., Koka, S., Migliorati, C. A., & Ristic, H. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0108 · Cited by 363
Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis
Mellström, D. D., Sörensen, O. H., Goemaere, S., Roux, C., Johnson, T. D., & Chines, A. A. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0286-7 · Cited by 350
Bisphosphonates for Osteoporosis — Where Do We Go from Here?
Whitaker, M., Guo, J., Kehoe, T., & Benson, G. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1202619 · Cited by 337
Miller, P. D., Mcclung, M. R., Macovei, L., Stakkestad, J. A., Luckey, M., Bonvoisin, B., Reginster, J.-Y., Recker, R. R., Hughes, C., Lewiecki, E. M., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050313 · Cited by 333
Self-citationEffect of Osteoporosis Treatment on Mortality: A Meta-Analysis
Bolland, M. J., Grey, A. B., Gamble, G. D., & Reid, I. R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0852 · Cited by 329
Atypical fractures of the femur and bisphosphonate therapy
Giusti, A., Hamdy, N. A. T., & Papapoulos, S. E. (2010) · Bone · doi:10.1016/j.bone.2010.05.019 · Cited by 295
Schwartz, A. V., Bauer, D. C., Cummings, S. R., Cauley, J. A., Ensrud, K. E., Palermo, L., Wallace, R. B., Hochberg, M. C., Feldstein, A. C., Lombardi, A., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.11 · Cited by 289
Self-citationEnsrud, K. E., Barrett-Connor, E. L., Schwartz, A., Santora, A. C., Bauer, D. C., Suryawanshi, S., Feldstein, A., Haskell, W. L., Hochberg, M. C., Torner, J. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040326 · Cited by 275
Self-citationGreen, J., Czanner, G., Reeves, G., Watson, J., Wise, L., & Beral, V. (2010) · BMJ · doi:10.1136/bmj.c4444 · Cited by 275
Delmas, P. D., Adami, S., Strugala, C., Stakkestad, J. A., Reginster, J., Felsenberg, D., Christiansen, C., Civitelli, R., Drezner, M. K., Recker, R. R., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21918 · Cited by 258
Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
Reid, I. R., Gamble, G. D., Mesenbrink, P., Lakatos, P., & Black, D. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0597 · Cited by 257
Fracture risk remains reduced one year after discontinuation of risedronate
Watts, N. B., Chines, A., Olszynski, W. P., McKeever, C. D., McClung, M. R., Zhou, X., & Grauer, A. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0460-7 · Cited by 237
Self-citationAlendronate and Atrial Fibrillation
Cummings, S. R., Schwartz, A. V., & Black, D. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmc076132 · Cited by 230
Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
Cardwell, C. R., Abnet, C. C., Cantwell, M. M., & Murray, L. J. (2010) · JAMA · doi:10.1001/jama.2010.1098 · Cited by 224
Reports of Esophageal Cancer with Oral Bisphosphonate Use
Wysowski, D. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0808738 · Cited by 198
Nevitt, M. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.1.77 · Cited by 196
Giusti, A., Hamdy, N. A. T., Dekkers, O. M., Ramautar, S. R., Dijkstra, S., & Papapoulos, S. E. (2011) · Bone · doi:10.1016/j.bone.2010.12.033 · Cited by 187
Bisphosphonate Use and the Risk of Adverse Jaw Outcomes
Cartsos, V. M., Zhu, S., & Zavras, A. I. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0016 · Cited by 183
Monitoring Osteoporosis Therapy: Bone Mineral Density, Bone Turnover Markers, or Both?
Bonnick, S. L., & Shulman, L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.12.020 · Cited by 182
Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men
Center, J. R., Bliuc, D., Nguyen, N. D., Nguyen, T. V., & Eisman, J. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2730 · Cited by 182
Incidence and demography of femur fractures with and without atypical features
Feldstein, A. C., Black, D., Perrin, N., Rosales, A. G., Friess, D., Boardman, D., Dell, R., Santora, A., Chandler, J. M., Rix, M. M., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1550 · Cited by 166
Oral bisphosphonates are associated with reduced mortality after hip fracture
Beaupre, L. A., Morrish, D. W., Hanley, D. A., Maksymowych, W. P., Bell, N. R., Juby, A. G., & Majumdar, S. R. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1411-2 · Cited by 165
Self-citationIncidence of stress fractures of the femoral shaft in women treated with bisphosphonate
Schilcher, J., & Aspenberg, P. (2009) · Acta Orthopaedica · doi:10.3109/17453670903139914 · Cited by 153
Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence?
Cryer, B., & Bauer, D. C. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.10.1031 · Cited by 148
Self-citationWang, Z., & Bhattacharyya, T. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.233 · Cited by 148
Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis
Strampel, W., Emkey, R. D., & Civitelli, R. (2007) · Drug Safety · doi:10.2165/00002018-200730090-00003 · Cited by 139
Leslie, W. D., Berger, C., Langsetmo, L., Lix, L. M., Adachi, J. D., Hanley, D. A., Ioannidis, G., Josse, R. G., Kovács, C. S., Towheed, T., et al. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1445-5 · Cited by 138
Self-citationFracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates
Gallagher, A. M., Rietbrock, S., Olson, M. S., & van Staa, T. P. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080510 · Cited by 135
Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
Curtis, J. R., Westfall, A. O., Cheng, H. T., Delzell, E., & Saag, K. G. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0604-4 · Cited by 135
Sambrook, P. N., Cameron, I. D., Chen, J. S., MARCH, L. M., Simpson, J. M., Cumming, R. G., & Seibel, M. J. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1444-6 · Cited by 127
Study Subjects and Ordinary Patients
Dowd, R. P., Recker, R. R., & Heaney, R. P. (2000) · Osteoporosis International · doi:10.1007/s001980070097 · Cited by 122
Siris, E. S., Pasquale, M. K., Wang, Y., & Watts, N. B. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.189 · Cited by 104
Newman, E. D., Ayoub, W. T., Starkey, R. H., Diehl, J. M., & Wood, G. C. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1336-5 · Cited by 103
Greenspan, S. L., Field-Munves, E., Tonino, R. P., Smith, M. E., Petruschke, R. A., Wang, L., Yates, J., de Papp, A. E., & Palmisano, J. J. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.10.1044 · Cited by 101
Miller, P. D., Epstein, S., Sedarati, F., & Reginster, J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079908x253889 · Cited by 100
Self-citationBisphosphonate-Associated Osteonecrosis of the Jaws and Endodontic Treatment: Two Case Reports
Sarathy, A. P., Bourgeois, S. L., & Goodell, G. G. (2005) · Journal of Endodontics · doi:10.1097/01.don.0000182737.09980.2c · Cited by 87
Yearly zoledronic acid in postmenopausal osteoporosis.
Karam, R., Camm, A. J., & McClung, M. R. (2007) · PubMed · Cited by 87
Self-citationMore on Reports of Esophageal Cancer with Oral Bisphosphonate Use
Abrahamsen, B., Eiken, P., & Eastell, R. (2009) · New England Journal of Medicine · doi:10.1056/nejmc096026 · Cited by 85
Harris, S. T., Reginster, J., Harley, C., Blumentals, W. A., Poston, S. A., Barr, C. E., & Silverman, S. L. (2009) · Bone · doi:10.1016/j.bone.2009.01.002 · Cited by 81
Self-citationBock, O., Börst, H., Thomasius, F. E., Degner, C., Stephan-Oelkers, M., Valentine, S. M., & Felsenberg, D. (2007) · PubMed · Cited by 61
Yearly Zoledronic Acid in Postmenopausal Osteoporosis
de Nijs, R. N. J., & Westgeest, A. A. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071514 · Cited by 59
Is Osteoporosis Disease Management Cost Effective?
Dell, R., & Greene, D. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0009-0 · Cited by 54
Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid
Olson, K. B., Hellie, C. M., & Pienta, K. J. (2005) · Urology · doi:10.1016/j.urology.2005.03.028 · Cited by 48
Comparative gastrointestinal safety of weekly oral bisphosphonates
Cadarette, S. M., Katz, J. N., Brookhart, M. A., Stürmer, T., Stedman, M. R., Levin, R., & Solomon, D. H. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0871-8 · Cited by 43
Subtrochanteric stress fracture of the femur following total knee arthroplasty
Kumm, D. A., Rack, C., & Rütt, J. (1997) · The Journal of Arthroplasty · doi:10.1016/s0883-5403(97)90184-4 · Cited by 42
Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials
Lewiecki, E. M., Cooper, C. C., Thompson, E., Hartl, F., Mehta, D., & Papapoulos, S. E. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02335.x · Cited by 37
Self-citationNiimi, R., Hasegawa, M., Sudo, A., & Uchida, A. (2008) · Journal of Orthopaedic Science · doi:10.1007/s00776-008-1262-2 · Cited by 20
Bonnick, S. L. (2011) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2011.07.006 · Cited by 18
Cited by
Compston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
Self-citationCamacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
Self-citationCamacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Self-citationCamacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.gl · Cited by 478
Self-citation
Metadata
- Authors
- McClung, M., Harris, S. T., Miller, P. D., Bauer, D. C., Davison, K. S., Dian, L., Hanley, D. A., Kendler, D. L., Yuen, C. K., & Lewiecki, E. M.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 126
- Issue
- 1
- Pages
- 13-20
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1994313426
- Cited by
- 451
- References
- 80
- FWCI
- 41.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.